A new cis-complementation system for nontypeable Haemophilus influenzae (NTHi) isolates
The
objective of this experiment was to design and construct a cis-complementation system for clinical isolates of nontypeable Haemophilus influenzae (NTHi).Two
strains were used in this study: a nasopharyngeal isolate from a child
with chronic otitis media, and a blood isolate from a child with
meningitis. The green fluorescent protein gene, gfp, was the reporter used in these experiments to insert as a
single copy. A pseudogene in the NTHI chromosome was chosen as the
recipient site for cis-complementation. A set of forward and reverse primers were
created that annealed to the 5’ end of the gene (first arm), amplifying 784
base pairs by Polymerase Chain Reaction (PCR), and another set that bound to
and amplified 791 base pairs of the 3’ end of the gene by PCR (second arm). The purpose for cloning
the first and second arm of the gene was to know exactly where the inserted DNA
was located.
To
create strains expressing gfp, a spectinomycin
antibiotic resistance cassette was added as a selection marker. Once the antibiotic cassette was inserted,
a gfp gene controlled by a strong
promoter was amplified and inserted between the two arms of the psuedogene. The
reason for the insertion of the reporter gene was to run assays and determine
if the gene was present. The antibiotic
cassette was used to insure that the gene would stay in. This resulted in the
antibiotic resistance cassette and the reporter gene being flanked by NTHi DNA
that is homologous to the pseudogene
locus. This construct was introduced into
the two NTHi strains by homologous recombination. The antibiotic-resistant transformants were
tested for GFP expression using fluorescence microscopy. By amplifying the
flanking regions and sequencing the products, we determined that the location
of the gfp gene was within the pseudogene. An immunoblot was performed to confirm gfp expression in both strains. Our next steps include using this
approach to complement existing NTHi deletion mutants in cis.